Dark

Check out our API

HLTH
Cue Health Inc. Common Stock
stock NASDAQ

Inactive

Jun 5, 2024

0.0434USD-29.773%(-0.0184)96,004,653

Pre-market

Dec 31, 1969 7:00:00 PM EST

0.00USD-100.000%(-0.06)0

After-hours

Dec 31, 1969 7:00:00 PM EST

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 11, 2022

08:36AM EST Cue Health : Preliminary Q4 Revenue Of $188 Mln To $193 Mln Vs. $13 Mln In Prior Year RTTNews

08:32AM EST Cue Health Sees Prelim. Q4 Revenue $188M-$193M vs $164.1M Est., Sees FY21 Sales $613M-$618M vs $588.91M Est. Benzinga

08:30AM EST Cue Health Reports Preliminary Fourth Quarter and Full Year 2021 Revenue Business Wire

Jan 6, 2022

09:30AM EST Cue Health To Develop Omicron-Genotyping COVID-19 Test RTTNews

09:15AM EST Cue Health To Develop Omicron-Genotyping COVID-19 Test In Partnership With US Department Of Health And Human Services' Biomedical Advanced Research And Development Authority (BARDA) Benzinga

09:15AM EST U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) PR Newswire

Jan 5, 2022

04:01PM EST Cue Health to Present at the 40th Annual J.P. Morgan Healthcare Conference Business Wire

Dec 27, 2021

12:02PM EST Cue Health Option Alert: Jun 17 $10 Calls at the Ask: 40 @ $6.65 vs 1338 OI; Earnings 2/25 Before Open [est] Ref=$15.015 Benzinga

10:22AM EST Cue Health Inc. (HLTH) shares are rising more than 17 percent on Monday morning trade, continuing a rally since December 17. There were no corporate announcements from the company today to impact the stock movement. RTTNews

Dec 21, 2021

09:17AM EST Air Canada Passengers Access Cue's 24/7 Supervised Test For Verified Travel Results Through Cue Health App RTTNews

09:16AM EST Cue Health Announces Partnership With Air Canada To Provide Us-Based Passengers With Access To Its Molecular COVID-19 Test Benzinga

09:15AM EST First-of-its-kind Cue Health Partnership with Air Canada Provides U.S.-based PR Newswire

Dec 16, 2021

09:16AM EST Cue Health Appoints Nitin Duggal as Chief Marketing Officer PR Newswire

Dec 1, 2021

09:19AM EST Cue Health Receives Singapore HSA Authorization For Its Molecular COVID-19 Test For Self-Testing Benzinga

09:16AM EST Cue Health Receives Singapore HSA Authorization for its Molecular COVID-19 Test PR Newswire

Nov 29, 2021

09:36AM EST Healthcare technology company Cue Health (HLTH) announced Monday it has completed an analysis of the SARS-CoV-2 B.1.1.529 variant, designated by the World Health Organization as Omicron. RTTNews

09:20AM EST Cue Health Says Has Completed Analysis Of Omicron Variant And Determined Its COVID-19 Tests Can Detect Omicron Variant Benzinga

09:17AM EST Cue Health Confirms COVID-19 Tests Can Detect Omicron Variant RTTNews

Nov 18, 2021

09:21AM EST Helix And Cue Health Collaborate To Provide Individuals With Access To Their COVID-19 Variant Sequencing Information Benzinga

09:16AM EST Helix, Cue Health Collaborate To Provide Individuals With Access To COVID-19 Variant Sequencing Information; Terms Not Disclosed Benzinga

09:16AM EST Helix and Cue Health Collaborate to Provide Individuals with Access to their PR Newswire

Nov 16, 2021

08:00AM EST Global Care Capital Inc. (CSE: HLTH, FRANKFURT: L6V2) (the Company or Global Care) a global investment company which engages in early-stage investment opportunities in private and public companies, is pleased to provide an update for its 100% owned portfolio company, ASIC Power Company (ASIC Power). GlobeNewswire Inc

Nov 11, 2021

07:38AM EST Cue Health Reports Q3 Profit On Higher Sales, Annual Guidance Above Consensus Benzinga

Nov 10, 2021

04:36PM EST Cue Health Sees FY21 Sales $580M-$590M Vs. $541.29M Est. Benzinga

04:35PM EST Cue Health Q3 EPS $0.13 Up From $(0.52) YoY, Sales $223.70M Up From $4.73M YoY Benzinga

04:01PM EST Cue Health Reports Third Quarter 2021 Financial Results Business Wire

04:09AM EST Earnings Scheduled For November 10, 2021 Benzinga

Nov 9, 2021

05:01AM EST Cue Health To Launch Direct-To-Consumer Virtual Health Platform Featuring Its PR Newswire

Nov 1, 2021

09:16AM EDT Cue Health Provides Molecular COVID-19 Testing To MLB Clubs During The PR Newswire

09:16AM EDT Cue Health Provides Molecular COVID-19 Testing To MLB Clubs During The Postseason And World Series Benzinga

Oct 27, 2021

04:01PM EDT Cue Health to Announce Third Quarter 2021 Financial Results Business Wire

Oct 19, 2021

10:02AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021 Benzinga

09:10AM EDT Morgan Stanley Initiates Coverage On Cue Health with Equal-Weight Rating, Announces Price Target of $12 Benzinga

06:46AM EDT Goldman Sachs Initiates Coverage On Cue Health with Buy Rating, Announces Price Target of $19 Benzinga

06:29AM EDT Cowen & Co. Initiates Coverage On Cue Health with Outperform Rating, Announces Price Target of $14 Benzinga

Oct 18, 2021

07:34AM EDT The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs Benzinga

Oct 14, 2021

09:17AM EDT Cue Health To Provide COVID-19 Testing For 2021-22 NBA Season RTTNews

Oct 6, 2021

09:16AM EDT Cue Health Collaborates With Google Cloud To Add Variant Sequencing, Tracking And Predictive Capabilities To Its Cue Platform Benzinga

09:16AM EDT Cue Health Reports Collab With Google Health 'To Add Variant Sequencing, Tracking, And Predictive Capabilities To Its Cue Platform' Benzinga

09:15AM EDT Cue Health Collaborates With Google Cloud To Add Variant Sequencing, Tracking, PR Newswire

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Oct 5, 2021

08:01AM EDT The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout Benzinga

Oct 1, 2021

07:56AM EDT The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO Benzinga

Sep 30, 2021

09:01AM EDT Cramer Gives His Opinion On Old Republic International, QuantumScape And More Benzinga

07:43AM EDT The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug Benzinga

Sep 24, 2021

11:38AM EDT Cue Health Shares Open For Trade At $16.76; IPO Priced At $16/Share Benzinga

09:33AM EDT List Of IPOs For Friday, Sept. 24, 2021: HLTH, CWAN, GIA.U, DSAQ Benzinga

09:29AM EDT Cue Health Shares Will Open For Quote At 10:10 a.m. EDT, Expected To Open For Trade After 10:20 a.m. EDT; IPO Priced At $16/Share Benzinga

Sep 23, 2021

09:13PM EDT Cue Health Prices IPO Of 12.50 Mln Shares At $16.00/shr RTTNews

09:00PM EDT Cue Health Announces Pricing of Initial Public Offering PR Newswire

Sep 19, 2021

09:46AM EDT The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions and Conference Presentations In The Spotlight Benzinga

Sep 1, 2021

05:46PM EDT Cue Health Files Registration Statement for Proposed Initial Public Offering PR Newswire

Share